{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:32:53Z","timestamp":1787740373290,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["AI065667-01A2"],"award-info":[{"award-number":["AI065667-01A2"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.11.018","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T09:38:58Z","timestamp":1290591538000},"page":"784-794","source":"Crossref","is-referenced-by-count":20,"title":["Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge"],"prefix":"10.1016","volume":"29","author":[{"given":"Dina","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra K.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nammalwar","family":"Sriranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Vemulapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2010.11.018_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.11.018_bib0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.018_bib0015","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1365-2672.2005.02622.x","article-title":"Brucellosis\u2014new aspects of an old disease","volume":"98","author":"Cutler","year":"2005","journal-title":"J Appl Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.11.018_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2010.11.018_bib0025","doi-asserted-by":"crossref","first-page":"D40","DOI":"10.1016\/j.vaccine.2009.08.058","article-title":"Brucellosis: the case for live, attenuated vaccines","volume":"27","author":"Ficht","year":"2009","journal-title":"Vaccine"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2010.11.018_bib0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.018_bib0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol Rev"},{"issue":"8874","key":"10.1016\/j.vaccine.2010.11.018_bib0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(93)91571-3","article-title":"Brucella melitensis Rev-1 vaccine as a cause of human brucellosis","volume":"342","author":"Blasco","year":"1993","journal-title":"Lancet"},{"issue":"69","key":"10.1016\/j.vaccine.2010.11.018_bib0045","first-page":"947","article-title":"A new species of Brucella isolated from the desert wood rat, Neotoma lepida Thomas","volume":"18","author":"Stoenner","year":"1957","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2010.11.018_bib0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-1119(95)00584-1","article-title":"Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes","volume":"166","author":"Kovach","year":"1995","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.018_bib0055","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1128\/IAI.68.6.3290-3296.2000","article-title":"Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses","volume":"68","author":"Vemulapalli","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.11.018_bib0060","first-page":"143","article-title":"Transformation of Brucella species with suicide and broad host-range plasmids","volume":"47","author":"McQuiston","year":"1995","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2010.11.018_bib0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/CDLI.12.12.1429-1436.2005","article-title":"Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51","volume":"12","author":"Sanakkayala","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2010.11.018_bib0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vetmic.2008.12.023","article-title":"Real-time PCR for identification of Brucella spp.: a comparative study of IS711, bcsp31 and per target genes","volume":"137","author":"Bounaadja","year":"2009","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2010.11.018_bib0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"8","key":"10.1016\/j.vaccine.2010.11.018_bib0080","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/S0021-9258(19)41574-3","article-title":"Fractions of Lipopolysaccharide from Escherichia coli O111-B4 prepared by two extraction procedures","volume":"250","author":"Morrison","year":"1975","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.018_bib0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2460\/ajvr.1989.50.03.311","article-title":"Chemical and protective properties of Brucella lipopolysaccharide obtained by butanol extraction","volume":"50","author":"Phillips","year":"1989","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.018_bib0090","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.68.6.3286-3289.2000","article-title":"Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51","volume":"68","author":"Vemulapalli","year":"2000","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2010.11.018_bib0095","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1128\/IAI.66.12.5684-5691.1998","article-title":"Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B abortus RB51","volume":"66","author":"Vemulapalli","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.11.018_bib0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.67.2.986-988.1999","article-title":"Vaccination with live Escherichia coli expressing Brucella abortus Cu\/Zn superoxide dismutase protects mice against virulent B. abortus","volume":"67","author":"Onate","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.11.018_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","article-title":"Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection","volume":"8","author":"Murali-Krishna","year":"1998","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.vaccine.2010.11.018_bib0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","article-title":"Biological properties of RB51; a stable rough strain of Brucella abortus","volume":"28","author":"Schurig","year":"1999","journal-title":"Vet Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.11.018_bib0115","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/IAI.58.9.2935-2939.1990","article-title":"Cloning expression, and occurrence of the Brucella Cu\u2013Zn superoxide dismutase","volume":"58","author":"Bricker","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.11.018_bib0120","first-page":"376","article-title":"The behavior of Brucella neotomae and Brucella suis in reciprocal superinfection experiments in mice and guinea pigs","volume":"24","author":"Stoenner","year":"1963","journal-title":"Am J Vet Res"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.018_bib0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4049\/jimmunol.95.4.759","article-title":"Studies on immunity in experimental leptospirosis: the immunogenicity of Leptospira icterohemorrhagiae attenuated by gamma-irradiation","volume":"95","author":"Hubbert","year":"1965","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.11.018_bib0130","first-page":"743","article-title":"Irradiated helminth larvae in vaccination","volume":"51","author":"Jarrett","year":"1958","journal-title":"Proc R Soc Med"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.018_bib0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.vaccine.2009.10.126","article-title":"Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB","volume":"28","author":"Martin","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.11.018_bib0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.immuni.2006.05.013","article-title":"Vaccination with irradiated Listeria induces protective T cell immunity","volume":"25","author":"Datta","year":"2006","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.vaccine.2010.11.018_bib0145","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/IAI.00231-09","article-title":"Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice","volume":"77","author":"Magnani","year":"2009","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.11.018_bib0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1574-6968.2000.tb09304.x","article-title":"Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis","volume":"190","author":"Dhar","year":"2000","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.018_bib0155","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-3083.2003.01321.x","article-title":"Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Gu\u00e9rin","volume":"58","author":"Rao","year":"2003","journal-title":"Scand J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2010.11.018_bib0160","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","article-title":"Selection of protective epitopes of Brucella melitensis by DNA vaccination","volume":"73","author":"Yang","year":"2005","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2010.11.018_bib0165","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1\u2013Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect Immun"},{"issue":"37\/38","key":"10.1016\/j.vaccine.2010.11.018_bib0170","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.018_bib0175","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<2003::AID-IMMU2003>3.0.CO;2-S","article-title":"Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells","volume":"28","author":"Ria","year":"1998","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.11.018_bib0180","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.4049\/jimmunol.172.10.6476","article-title":"IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis","volume":"172","author":"Sharif","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.018_bib0185","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1128\/IAI.63.3.1130-1133.1995","article-title":"Interleukin-10 downregulates protective immunity to Brucella abortus","volume":"63","author":"Fernandes","year":"1995","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2010.11.018_bib0190","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.11.018_bib0195","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1128\/IAI.01787-05","article-title":"Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB\/c mice","volume":"74","author":"Kahl-McDonagh","year":"2006","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2010.11.018_bib0200","doi-asserted-by":"crossref","first-page":"e2760","DOI":"10.1371\/journal.pone.0002760","article-title":"Brucellosis vaccines: assessment of Brucella melitensis lipopolysacharide rough mutants defective in core and O-polysaccharide synthesis and export","volume":"3","author":"Gonzalez","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.018_bib0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/713608012","article-title":"T cell immunity to brucellosis","volume":"29","author":"Yingst","year":"2003","journal-title":"Crit Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.018_bib0210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0769-2625(87)80052-1","article-title":"Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine brucellosis","volume":"138","author":"Limet","year":"1987","journal-title":"Ann Inst Pasteur Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.11.018_bib0215","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.143.10.3330","article-title":"Temporal development of protective cell-mediated and humoral immunity in BALB\/c mice infected with Brucella abortus","volume":"143","author":"Araya","year":"1989","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.018_bib0220","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/IAI.51.3.961-963.1986","article-title":"Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies","volume":"51","author":"Montaraz","year":"1986","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.018_bib0225","first-page":"651","article-title":"Antibody-mediated protection against Brucella abortus in BALB\/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19","volume":"82","author":"Elzer","year":"1994","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.018_bib0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-2478(94)90078-7","article-title":"BALB\/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes","volume":"42","author":"Elzer","year":"1994","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2010.11.018_bib0235","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/IAI.60.1.312-315.1992","article-title":"Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides","volume":"60","author":"Cloeckaert","year":"1992","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2010.11.018_bib0240","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1128\/IAI.69.7.4407-4416.2001","article-title":"Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis","volume":"69","author":"Fernandez-Prada","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.018_bib0245","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1128\/IAI.71.4.2110-2119.2003","article-title":"Interaction between Brucella melitensis and human phagocytes: bacterial surface O-polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis","volume":"71","author":"Fernandez-Prada","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.018_bib0250","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/CDLI.5.6.862-870.1998","article-title":"O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry","volume":"5","author":"Cloeckaert","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.11.018_bib0255","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/IAI.46.2.384-388.1984","article-title":"Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3","volume":"46","author":"Caroff","year":"1984","journal-title":"Infect Immun"},{"issue":"26","key":"10.1016\/j.vaccine.2010.11.018_bib0260","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1021\/bi00400a034","article-title":"Structural elucidation of the Brucella melitensis M antigen by high-resolution NMR at 500MHz","volume":"26","author":"Bundle","year":"1987","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.018_bib0265","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/IAI.00767-07","article-title":"Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge","volume":"76","author":"Arenas-Gamboa","year":"2008","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:06:46Z","timestamp":1740719206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10016269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10016269"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}